targeted therapy

Atezolizumab plus bevacizumab combination is positive for untreated metastatic kidney cancer

By Sharon Kell|2018-02-06T15:34:35+00:006 Feb 2018|Drug treatments|

The combination of immunotherapy atezolizumab (Tecentriq) with targeted therapy bevacizumab [...]

Read More

Comments Off on Atezolizumab plus bevacizumab combination is positive for untreated metastatic kidney cancer

• 

Surgery improves survival in metastatic kidney cancer

By Sharon Kell|2017-12-11T10:55:33+00:0011 Dec 2017|Surgery|

Researchers from the University of Washington Medical Center in Seattle [...]

Read More

Comments Off on Surgery improves survival in metastatic kidney cancer

MicroRNA as a potential biomarker for kidney cancer

By Sharon Kell|2017-07-31T08:23:05+00:0031 Jul 2017|Cancer news|

Recently, researchers are focusing on microRNAs (miRNAs) circulating in the [...]

Read More

Comments Off on MicroRNA as a potential biomarker for kidney cancer

• 

Management of renal medullary carcinoma

By Sharon Kell|2017-05-10T16:02:57+00:0010 May 2017|Drug treatments, Subtypes of RCC|

Renal medullary carcinoma is a very rare subtype of renal [...]

Read More

Comments Off on Management of renal medullary carcinoma

• 

Nephrectomy adds benefit to targeted therapies in metastatic kidney cancer

By Sharon Kell|2016-06-23T17:04:32+00:0023 Jun 2016|Cancer news|

A recent study in America has shown that cytoreductive nephrectomy [...]

Read More

Comments Off on Nephrectomy adds benefit to targeted therapies in metastatic kidney cancer